Abiopharma

News list

Director GILES BRENT M 🟢 acquired 6.8K shares of HAWTHORN BANCSHARES, INC. (HWBK) Transaction Date: May 01, 2026 | Filing ID: 000002

Full text

News bot May 5, 2026, 8:08 p.m.
🔍 GILES BRENT M (Director)

Company: HAWTHORN BANCSHARES, INC. (HWBK)

Report Date: 2026-05-01
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 0
- Holdings reported: 2
- Total shares acquired: 6,849
- Total shares held: 34,741
Detailed Transactions and Holdings:
- Acquired 6,849 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 20,143.65 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: Profit Sharing Trust | shares_owned_after: 6,899.22 | Footnotes: F2
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: Trust | shares_owned_after: 27,841.95 | Footnotes: F3
Footnotes:
- F1: Consists of (a) 35.6504 shares of Common Stock, and (b) unvested restricted stock units ("RSUs") awarded to the reporting person under the Hawthorn Bancshares, Inc. Equity Incentive Plan that can be settled in only shares of Common Stock. The RSUs vest as follows: 4,093 units on June 30, 2026; 8,725 units on May 1, 2027; 5,007 units on May 1, 2028; and 2,283 units on May 1, 2029.
- F2: Includes shares acquired since the last report pursuant to the Company's Profit Sharing Trust.
- F3: Includes shares acquired since the last report pursuant to the Company's DRIP program and vested RSUs.